Court Sets Preliminary $15 Million Settlement in Allergan Subsidiary Antitrust Case

A federal judge signed off on a $15 million settlement to close out claims of anticompetitive behavior by Allergan and its subsidiary Warner Chilcott.
Source: Drug Industry Daily